Immunodetection of aldose reductase in normal and diseased human liver

Histology and Histopathology

Volumn 20, Issue 2, 2005, Pages 429-436

  Brown, Kyle E ^a,b   Broadhurst, K A ^a   Mathahs, M M ^a   Kladney, R D ^c   Fimmel, C J ^c,d   Srivastava, S K ^e   Brunt, E M ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

4 hydroxy 2 nonenal; Aldo keto reductase; Kupffer cells; Macrophages; Polyol pathway

Indexed keywords

ALDEHYDE REDUCTASE; CD48 ANTIGEN; MESSENGER RNA;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOBLOTTING; IMMUNODETECTION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; KUPFFER CELL; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER SINUSOID; LUNG; LYMPH NODE; MACROPHAGE; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ALDEHYDE REDUCTASE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA, COMPLEMENTARY; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KUPFFER CELLS; LIVER; LIVER DISEASES; MACROPHAGES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 16444379233     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bhatnagar A., Ruef J., Liu S.Q., Srivastava S. and Srivastava S.K. (2001). Regulation of vascular smooth muscle cell growth by aldose reductase. Chemico-Biological Interactions 130-132, 627-636.
2. Brown K.E. (2000. An overview of hepatic fibrogenesis. Viral Hep. Rev. 6, 5-27.
3. Brownlee M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414, 8813-8820.
4. Cao D., Fan S.T. and Chung S.S.M. (1998). Identification and characterization of a novel human aldose reductase-like gene. J. Biol. Chem. 273, 11429-11435.
5. Esterbauer H., Schaur R.J. and Zollner H. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical. Biol. Med. 11, 81-128.
6. Gaweco A.S., Wiesner R.H., Porayko M., Rustgi V.K., Yong S., Hamdani R., Harig J., Chejfec G., McClatchey K.D. and Van Thiel D.H. (2000). Intragraft localization of activated nuclear factor κB in recurrent hepatitis C virus disease following liver transplantation. Hepatology 31, 1183-1191.
7. Hers H.G. (1960). L'aldose reductase. Biochim. Biophys. Acta 37, 120-126.
8. Kawamura I., Lacey E., Yamamoto N., Sakai F., Takeshita S., Inami M., Nishigaki F., Naoe Y., Tsujimoto S., Manda T., Shimomura K. and Goto T. (1999). Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice. Anticancer Res. 19, 4105-4112.
9. Kladney R.D., Cui X., Bulla G.A., Brunt E.M. and Fimmel C.J. (2002). Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 35, 1431-1440.
10. Kristensen D.B., Kawada N., Imamura K., Miyamoto Y., Tateno C., Seki S., Kuroki T. and Yoshizato K. (2000). Proteome analysis of rat hepatic stellate cells. Hepatology 32, 268-277.
11. Lee K.W.Y., Ko B.C.B., Jiang Z., Cao D. and Chung S.S.M. (2001). Overexpression of aldose reductase in liver cancers may contribute to drug resistance. Anti-Cancer Drugs 12, 129-132.
12. Nanji A. (2002). Role of Kupffer cells in alcoholic hepatitis. Alcohol 27, 13-15.
13. Nishimura C., Graham C., Hohman T.C., Nagata M., Robinson W.G. and Carper D. (1988). Characterization of mRNA and genes for aldose reductase in rat. Biochem. Biophys. Res. Commun. 153, 1057-1059.
14. 1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem. J. 343, 487-504.
15. Ramana K.V., Chandra D., Srivastava S., Bhatnagar A., Aggarwal B.B. and Srivastava S.K. (2002). Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells. J. Biol. Chem. 277, 32063-32070.
16. Ramana K.V., Friedrich B., Bhatnagar A. and Srivastava S.K. (2003). Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-α in human lens epithelial cells. FASEB J. 17, 315-317.
17. Ramasamy R., Oates P.J. and Schaefer S. (1997). Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury. Diabetes 46, 292-300.
18. Rittner H.L., Hafner V., Klimiuk P.A., Szweda L.I., Goronzy J.J. and Weyand C.M. (1999). Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J. Clin. Invest. 103, 1007-1013.
19. Ruef J., Liu S.Q., Bode C., Tocchi M., Srivastava S., Runge M.S. and Bhatnagar A. (2000). Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury. Arterioscler. Thromb. Vasc. Biol. 20, 1745-1752.
20. Siems W.G., Zollner H., Grune T. and Esterbauer H. (1997). Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dyhydroxynonene is not the main product. J. Lipid Res. 38, 612-622.
21. Spycher S.E., Tabataba-Vakili S., O'Donnell V.B., Palomba L. and Azzi A. (1996). 4-Hydroxy-2-nonenal induces transcription and expression of aldose reductase. Biochem. Biophys. Res. Commun. 226, 512-516.
22. Spycher S.E., Tabataba-Vakili S., O'Donnell V. B., Palomba L. and Azzi A. (1997). Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells. FASEB J. 11, 181-188.
23. Srivastava S.K., Ansari N.H., Nair G.A. and Das B. (1984). Aldose and aldehyde reductases in human tissues. Biochim. Biophys. Acta 800, 220-227.
24. Srivastava S., Chandra A., Bhatnagar A., Srivastava S. K. and Ansari N. H. (1995). Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase. Biochem. Biophys. Res. Comm. 217, 741-746.
25. Takahashi M., Hoshi A., Fujii J., Miyoshi E., Kasahara T., Suzuki D., Aozasa K. and Taniguchi N. (1996). Induction of aldose reductase gene expression in LEC rats during the development of hereditary hepatitis and hepatoma. Jpn. J. Cancer Res. 87, 337-341.
26. 3 agonist reduces ischemic myocardial injury. Am. J. Physiol. Heart. Circ. Physiol. 279, H1447-H1452.
27. Tulsiani D.R.P. and Touster O. (1977). Resolution and partial characterization of two aldehyde reductases of mammalian liver. J. Biol. Chem. 252, 2545-2550.
28. Vander Jagt D.L., Hunsaker L.A., Robinson B., Stangebye L.A. and Deck L.M. (1990). Aldehyde and aldose reductase from human placenta. J. Biol. Chem. 265, 10912-10918.
29. Vander Jagt D.L., Kolb N.S., Vander Jagt T.J., Chino J., Martinez F.J., Hunsaker LA. and Royer R.E. (1995). Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. Biochim. Biophys. Acta 1249, 117-126.
30. Wirth H-P. and Wermuth B. (1984). Immunohistochemical localisation of aldehyde and aldose reductase in human tissues. Progr. Clin. Biol. Res. 74, 231-239.